- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.07. | UK's Mission divests kidney drug to Dimerix for $292m | ||
| 17.07. | GSK abandons cough drug added in $2bn Bellus deal | ||
| 17.07. | Radiopharma firm AdvanCell raises $315m, and other financings | ||
| 17.07. | UK experts call for meningitis shots for all 15-year-olds | ||
| 16.07. | MSD gets first FDA okay for oral PCSK9 cholesterol drug | ||
| 16.07. | Lilly buys into psychedelics with $3.8bn AtaiBeckley deal | ||
| 16.07. | England to start screening newborns for rare disease SMA | ||
| 16.07. | Two more biotechs, Attovia and Braveheart, join the IPO line | ||
| 16.07. | Bayer's Kerendia on course for NHS use in heart failure | ||
| 16.07. | Novo's Wegovy pill cleared for weight loss in EU | ||
| 15.07. | AI specialist Chai Discovery raises $400m | ||
| 15.07. | Could microplastics be linked to cardiovascular disease? | ||
| 15.07. | Celcuity gets FDA nod for first-in-class breast cancer drug | ||
| 14.07. | Biogen, Ionis trumpet Alzheimer's data, but shares dip | ||
| 14.07. | New biotech Avere plots listing via NextCure merger | ||
| 14.07. | Spero snaps up Innovent immunology drug in strategic pivot | ||
| 14.07. | Digital check-ins improve cancer care and reduce inequality | ||
| 14.07. | AstraZeneca adds another Chinese asset, from Dizal | ||
| 14.07. | First trial of Bundibugyo Ebola vaccine starts in UK | ||
| 14.07. | FDA clears at-home start dose for Alzheimer's drug Leqembi | ||
| 13.07. | Major trial launched to explore GLP-1 benefit in dementia | ||
| 13.07. | GSK to file Jemperli for rectal cancer after phase 3 readout | ||
| 13.07. | EU warns of brain tumour risk with some contraceptives | ||
| 13.07. | Pay offer rejected as ICR researchers continue strike action | ||
| 13.07. | Sleep apnoea drug firm Apnimed files for IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.